Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5

NCT02314208 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER_GOV

Sponsor class

Conditions

Spastic Paraplegia, Hereditary

Interventions

DRUG: Xenbilox
DIETARY_SUPPLEMENT: Resveratrol
DRUG: Tahor

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France